Statin

Statin - most related articles:

- Intensive statin therapy increases risk of diabetes - 5.9
- Statin use reduces Parkinson Disease risk - 4.8
- Red yeast rice reduce cholesterol in statin intolerant - 4.6
- Statins, cholesterol lowering drugs may not prevent Alzheimer's Disease - 4.1
- Statin may raise stroke risk in patients with brain hemorrhage - 3.9
- Vytorin does not appear to be unsafe - American Heart Association - 3.6
- Statins lower prostate cancer recurrence after prostatectomy - 3.5
- Niacin and statin treatment did not protect heart - 3.3
- Safety changes in labeling for cholesterol lowering drugs statins - 3.1
- Statins may cause muscle damage in some patients - 3

Statin articles

Statin use reduces Parkinson Disease risk
Regular use of cholesterol-lowering statin drugs may be associated with a modest reduction in risk for developing Parkinson disease, particularly among younger patients. Statins are one of the most prescribed classes of drugs in the United States.

Safety changes in labeling for cholesterol lowering drugs statins
Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins are being announced by the U.S. Food and Drug Administration. These products, when used with diet and exercise, help to lower a person's "bad cholesterol (low-density lipoprotein cholesterol).

Cholesterol lowering drugs statins may help hospitalized influenza patients
The two main ways to prevent and control influenza today are annual immunization and antiviral drugs. A team of investigators has found that statins, cholesterol-lowering drugs, may offer an additional treatment to complement these approaches and reduce mortality among patients hospitalized with influenza.

Evacetrapib can increase good cholesterol HDL
Researchers at Cleveland Clinic reported that administration of a new drug– evacetrapib – can dramatically increase HDL (good) cholesterol, while significantly lowering LDL (bad) cholesterol). At the highest tested dosage, the levels of HDL more than doubled.

Intensive statin therapy increases risk of diabetes
Use of intensive-dose statin therapy compared with moderate-dose statin therapy was associated with a higher incidence of new-onset diabetes. An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the recent issue of JAMA.

New safety recommendations for high dose 80 mg simvastatin
Patients taking simvastatin 80 mg daily had an increased risk of muscle injury. The risk of muscle injury is highest during the first year of treatment with the 80 mg dose of simvastatin, and is frequently associated with a genetic predisposition for simvastatin-related muscle injury or myopathy.

Niacin and statin treatment did not protect heart
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned.

Statins not for low risk patients
There is not enough evidence to recommend the widespread use of statins in people with no previous history of heart disease, according to a new Cochrane Systematic Review.

Statin may raise stroke risk in patients with brain hemorrhage
People with brain hemorrhage - a type of stroke - should avoid taking cholesterol lowering drugs called statins, revealed by researchers in US.

Statins lower prostate cancer recurrence after prostatectomy
Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also found that higher doses of the drugs were associated with lower risk of recurrence.

Statin and BP drug combo ALL prevents heart attack and stroke
Low-cost drugs – a cholesterol-lowering statin and a blood pressure-lowering drug – as daily doses to 68,560 people with diabetes or heart disease for two years is estimated to have prevented 1,271 heart attacks and strokes.

Schistosomiasis parasite's Schistosoma mansoni's Genome decoded
Researchers have sequenced the genome of the parasite -- Schistosoma mansoni -- that causes intestinal schistosomiasis (also known as bilharzia or snail fever), a devastating tropical disease that afflicts more than 200 million people in the developing world.

Statins may cause muscle damage in some patients
Structural muscle damage may be present in patients who have statin-associated muscle complaints, found a new study in CMAJ (Canadian Medical Association Journal).

Heart disease mortality decreased 30% in Canada
Hospital admissions and mortality for heart diseases (cardiovascular disease) declined 30% over a 10-year period in Canada, revealed by canadian researchers.

Red yeast rice reduce cholesterol in statin intolerant
Red yeast rice capsules reduce cholesterol LDL (low density lipoprotein) levels in statin intolerant patients without causing any adverse events such as muscle pain and weakness, revealed by researchers.

Lipoprotein a increases heart attack risk
A genetic analysis of data from three studies suggests that genetically elevated levels of lipoprotein(a) are associated with an increased risk of heart attack, according to a study in the June 10 issue of JAMA.

Statins may help prevent stroke recurrence
People who take cholesterol-lowering drugs called statins after a stroke may be less likely to have another stroke later, according to research published in the May 26, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.

A breakthrough in floppy baby syndrome research
In a world first, West Australian scientists have cured mice of a devastating muscle disease that causes a Floppy Baby Syndrome – a breakthrough that could ultimately help thousands of families across the globe.

Down syndrome patients have a reduced risk for cancer
Most cancers are rare in people with Down syndrome, whose overall cancer mortality is below 10 percent of that in the general population.

Statins reduce inflammation in prostate tumors
Cholesterol lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center.

Crestor reduced blood clots in the veins
A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).

$60 m for tuberculosis and HIV research in South Africa
A groundbreaking partnership between the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN) in South Africa will establish an international research center focused on making major scientific contributions to the worldwide effort to control the devastating co-epidemic of tuberculosis (TB) and HIV and on training a new generation of scientists in Africa.

Australia in the front line for outbreaks of diseases
Australia is surrounded to its north by a ‘ring of fire' where new human and animal plagues are likely to erupt without warning, with potentially devastating consequences.

Scientists isolate genes that made 1918 flu lethal
By mixing and matching a contemporary flu virus with the "Spanish flu" - a virus that killed between 20 and 50 million people 90 years ago in history's most devastating outbreak of infectious disease - researchers have identified a set of three genes that helped underpin the extraordinary virulence of the 1918 virus.

Genetic disease recreated in lab
When neurons started dying in Clive Svendsen's lab dishes, he couldn't have been more pleased. The dying cells – the same type lost in patients with the devastating neurological disease spinal muscular atrophy – confirmed that the University of Wisconsin-Madison stem cell biologist had recreated the hallmarks of a genetic disorder in the lab, using stem cells derived from a patient.

Vitamin C lowers heart disease biomarker
A new study led by researchers at the University of California, Berkeley, adds to the evidence that vitamin C supplements can lower concentrations of C-reactive protein (CRP), a central biomarker of inflammation that has been shown to be a powerful predictor of heart disease and diabetes.

New risk factor for cardiovascular disease
A team of international researchers - including scientists from the McGill University Health Centre (MUHC) and McGill University - have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease.

Statins do not increase risk of Lou Gehrig's Disease
A U.S. Food and Drug Administration's analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as "Lou Gehrig's Disease." The analysis was reported on Monday, Sept. 29, 2008 in Pharmacoepidemiology and Drug Safety.

$1 million help to find Alzheimer's disease cure
UK's best-selling author, Terry Pratchett, has pledged $1million to leading UK charity, the Alzheimer's Research Trust, in a bid to help find a cure for the devastating disease, with which he was diagnosed in December 2007.

New chemical tool kit reveals insights into drug toxicity
Why do nearly 1 million people taking cholesterol-lowering statins often experience muscle cramps? Why is it that in the rare case when a diabetic takes medication for intestinal worms, his glucose levels improve? Is there any scientific basis for the purported health effects of green tea?

Cholesterol drug statins may reduce heart's atrial fibrillation
When we're young, a racing heart often means love is in the air. If you're a "baby boomer," it might mean you've just joined the 2.2 million Americans who have atrial fibrillation (AF), an irregularity in the heart's rhythm that grows more common as we age and markedly increases the risk for stroke.

Ongoing review of cholesterol drug Vytorin
The U.S. Food and Drug Administration (FDA) is informing the public that the agency will conduct a review of Merck and Schering Plough's recent trial once the FDA receives the final study results.

Climate change a threat to human health
Climate change will have a huge impact on human health and bold environmental policy decisions are needed now to protect the world's population, according to the author of an article published in the British Medical Journal (BMJ).

Genes linked with lupus giving hope for new treatments
Scientists have identified a number of genes involved in Lupus, a devastating autoimmune disease, in new research published today in the journal Nature Genetics. In an international genetic study of more than 3,000 women, researchers found evidence of an association between Lupus (systemic lupus erythematosus or SLE) and mutations in several different genes.

Vytorin does not appear to be unsafe - American Heart Association
Merck/Schering-Plough Pharmaceuticals released results from the ENHANCE trial, which found that the ezetimibe/simvastatin (Zetia/Zocor) combination drug known as Vytorin was no more effective in reducing artery plaque build-up than simvastatin (Zocor) alone. There were no statistically significant differences in the safety of the drugs, which are used to lower cholesterol.

Statins, cholesterol lowering drugs may not prevent Alzheimer's Disease
Taking statins, which are cholesterol-lowering drugs, offers no protection against Alzheimer's disease, revealed by US researchers at Rush University Medical Center in Chicago.

Compstatin - new drug for vision loss, macular degeneration
University of Florida UF scientists are testing the safety of experimental drug Compstatin for vision loss in macular degeneration patients. In a first-of-its-kind safety research study, University of Florida researchers have injected an anti-inflammatory compound into the eye of a person with a sight-robbing disease.

Sulforaphane in broccoli could treat genetic skin disorder
The compound sulforaphane whose natural precursors are found at high levels in broccoli and other cruciferous vegetables has been hailed for its chemopreventive powers against cancer. Now sulforaphane has demonstrated new skills in treating a genetic skin blistering disorder called epidermolysis bullosa simplex (EBS), Pierre Coulombe and colleagues at the Johns Hopkins University School of Medicine in Baltimore report at the American Society for Cell Biology 47th Annual Meeting.

38 Statin articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.39